“We are a tech company.”
The stock has been on fire since August, and CEO Corey Giasson says innovation is much of the reason for the success of Mustgrow Biologics (Mustgrow Biologics Stock Quote, Chart, News, Analysts, Financials TSXV:MGRO).
Mustgrow is a Saskatchewan-based AgTech company that uses materials from mustard plant to create organic biocontrol and biofertility products.
“We are a tech company,” Giasson told MacArthur. “IP is very important to us and we continue to generate more IP. We have about 112 patents right now. But it’s quite exciting to turn the corner and start the commercialization process and continue to generate revenue and hopefully in the near future, positive cash flow.”
And while 2024 has been a great year for MGRO investors, it has been very eventful from a corporate perspective, too.
“2024 has been a great year,” he said. “At the end of 2023 we partnered with Bayer, the largest AgChem company in the world. We have a commercial partnership with them now in Europe, The Middle East and Africa, and in 2024 we have registrations for our biofertility product in the United States, with sales starting.”
See below for the full interview:
About The Author /
Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
RELATED POSTS
Share
Tweet
ShareTRENDING
All Trending →
High Tide stock is a buy, Ventum says
December 3, 2024
Oh my, Shopify!
November 12, 2024
Is Constellation Software still a buy? (November, 2024)
November 12, 2024
Is WELL Health’s $4-billion plan possible? Raymond James says yes.
November 11, 2024
Comment